{"id":"https://openalex.org/W295522154","doi":null,"title":"[Effect of AChE and BuChE inhibition by rivastigmin in a group of old-old elderly patients with cerebrovascular impairment (SIVD type)].","display_name":"[Effect of AChE and BuChE inhibition by rivastigmin in a group of old-old elderly patients with cerebrovascular impairment (SIVD type)].","publication_year":2014,"publication_date":"2014-04-01","ids":{"openalex":"https://openalex.org/W295522154","mag":"295522154","pmid":"https://pubmed.ncbi.nlm.nih.gov/24727881"},"language":"it","primary_location":{"id":"pmid:24727881","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24727881","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minerva medica","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016809243","display_name":"Adriana Servello","orcid":"https://orcid.org/0000-0002-8197-5904","observed_orcids":["https://orcid.org/0000-0002-8197-5904"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A Servello","raw_affiliation_strings":["Dipartimento di Sanit\u00e0 Pubblica e Malattie Infettiva La Sapienza Universit\u00e0 di Roma, Roma, Italia - adriana.servello@uniroma1.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Sanit\u00e0 Pubblica e Malattie Infettiva La Sapienza Universit\u00e0 di Roma, Roma, Italia - adriana.servello@uniroma1.it","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077743530","display_name":"P. Andreozzi","orcid":"https://orcid.org/0000-0003-0369-8750","observed_orcids":["https://orcid.org/0000-0003-0369-8750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Andreozzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079864131","display_name":"F Bechini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Bechini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R De Angelis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R De Angelis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110585948","display_name":"Pontecorvo Ml","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M L Pontecorvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"A Vulcano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Vulcano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015858611","display_name":"E Cerra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Cerra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030224059","display_name":"Maria Teresa Vigliotta","orcid":"https://orcid.org/0009-0003-0997-6501","observed_orcids":["https://orcid.org/0009-0003-0997-6501"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M T Vigliotta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017757243","display_name":"Marco Artini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Artini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076209466","display_name":"Laura Selan","orcid":"https://orcid.org/0000-0002-2413-7349","observed_orcids":["https://orcid.org/0000-0002-2413-7349"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Selan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056676511","display_name":"Evaristo Ettorre","orcid":"https://orcid.org/0000-0002-8247-3308","observed_orcids":["https://orcid.org/0000-0002-8247-3308"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Ettorre","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6441,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.67820262,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"105","issue":"2","first_page":"167","last_page":"74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.5044000148773193,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.5044000148773193,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.40310001373291016,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":0.07810000330209732,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rivastigmine","display_name":"rivastigmine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibition","display_name":"acetylcholinesterase inhibition","score":0.8629999756813049},{"id":"https://openalex.org/keywords/butyrylcholinesterase-inhibition","display_name":"butyrylcholinesterase inhibition","score":0.996999979019165},{"id":"https://openalex.org/keywords/vascular-dementia","display_name":"vascular dementia","score":0.8309999704360962},{"id":"https://openalex.org/keywords/subcortical-ischemic-vascular-dementia","display_name":"subcortical vascular dementia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/cognitive-decline","display_name":"cognitive decline","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7300000190734863},{"id":"https://openalex.org/keywords/mood","display_name":"mood","score":0.36800000071525574},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.9503852128982544},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.8466213941574097},{"id":"https://openalex.org/C2777952318","wikidata":"https://www.wikidata.org/wiki/Q583908","display_name":"Vascular dementia","level":4,"score":0.8125315308570862},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.7240471243858337},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6832727193832397},{"id":"https://openalex.org/C31896038","wikidata":"https://www.wikidata.org/wiki/Q415635","display_name":"Cholinesterase","level":2,"score":0.6044005155563354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5484989881515503},{"id":"https://openalex.org/C2779059548","wikidata":"https://www.wikidata.org/wiki/Q383701","display_name":"Ach\u00e9","level":4,"score":0.5092707872390747},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.4219311475753784},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2910897135734558},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.05303731560707092},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068836","descriptor_name":"Rivastigmine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000110","descriptor_name":"Acetylcholinesterase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002091","descriptor_name":"Butyrylcholinesterase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008609","descriptor_name":"Mental Status Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015140","descriptor_name":"Dementia, Vascular","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D015140","descriptor_name":"Dementia, Vascular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D048448","descriptor_name":"Phenylcarbamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:24727881","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24727881","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Minerva medica","raw_type":"Journal Article"},{"id":"pmh:oai:iris.uniroma1.it:11573/574395","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/574395","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:295522154","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24727881","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2105024630","https://openalex.org/W2184923050","https://openalex.org/W4247423148","https://openalex.org/W2162252402","https://openalex.org/W1781335438","https://openalex.org/W2051601876","https://openalex.org/W2356719495","https://openalex.org/W2066038355","https://openalex.org/W2050004747","https://openalex.org/W2606010066"],"abstract_inverted_index":{"AIM:":[0],"Vascular":[1],"dementia":[2,43,58],"(VaD)":[3],"is":[4,49,250],"defined":[5],"as":[6,214,254],"a":[7,80,196,201,258,274],"loss":[8],"of":[9,30,71,103,207,226,233,268,276],"cognitive":[10,104,235,281],"function":[11],"resulting":[12],"from":[13],"ischemic,":[14],"hypoperfusive,":[15],"or":[16,24],"hemorrhagic":[17],"brain":[18],"lesions":[19],"due":[20],"to":[21,76,92,252],"cerebrovascular":[22],"disease":[23,40],"cardiovascular":[25],"pathology.":[26],"The":[27,47,237],"main":[28,53],"types":[29],"VaD":[31],"are:":[32],"Small":[33],"Vessel":[34],"Disease":[35],"Dementia":[36],"(sVAD),":[37],"Large":[38],"vessel":[39],"dementia,":[41],"hypoperfusive-ischemic":[42],"and":[44,60,97,115,131,172,200,246],"hemorragic":[45],"dementia.":[46,62],"sVAD":[48],"divided":[50,160],"into":[51,161],"two":[52,162],"categories:":[54],"subcortical":[55],"ischemic":[56],"vascular":[57],"(SIVD)":[59],"cortical":[61],"Currently,":[63],"no":[64],"drugs":[65],"are":[66],"approved":[67],"for":[68,87,153,192],"the":[69,88,101,140,179,215,227,269],"treatment":[70,147,208],"VaD.":[72,108,135],"This":[73],"study":[74,141],"aimed":[75],"determine":[77],"whether":[78],"rivastigmine,":[79],"second":[81,202],"generation":[82],"cholinesterase":[83],"inhibitor":[84],"with":[85,90,107,122,148,168,182,195,224,266,285],"selectivity":[86],"CNS,":[89],"capacity":[91],"inhibit":[93],"both":[94],"acetylcholinesterase":[95],"(AChE)":[96],"butyryl-cholinesterase":[98],"(BuChE),":[99],"slows":[100],"rate":[102],"decline":[105,232],"associated":[106],"METHODS:":[109],"Study":[110],"subjects":[111],"were":[112,137,144,159,190],"27":[113],"male":[114],"43":[116],"female":[117],"outpatients":[118],"aged":[119],"80.03\u00b16.53":[120],"years,":[121],"Mini-Mental":[123],"State":[124],"Examination":[125],"(MMSE)":[126],"score":[127],"ranging":[128],"batween":[129],"22":[130],"12,":[132],"affected":[133],"by":[134],"They":[136],"included":[138],"in":[139,242,261,264,283],"if":[142],"they":[143],"undergoing":[145],"pharmacological":[146],"acetylsalicylic":[149],"acid":[150],"100":[151,170,184],"mg":[152,171,176,185],"at":[154,221],"least":[155],"six":[156,205],"months.":[157],"Patients":[158],"groups:":[163],"one":[164],"group":[165,217,229,271],"was":[166,240],"treated":[167],"ASA":[169,183,228,270],"rivastigmine":[173],"patch":[174],"9.5":[175],"(Rivastigmine":[177],"group),":[178],"other":[180],"just":[181],"(ASA":[186],"group).":[187],"All":[188],"patients":[189,225,256,267],"followed":[191],"6":[193],"months,":[194],"first":[197],"evaluation":[198],"(T0)":[199],"examination":[203],"after":[204],"mounths":[206],"(T1).":[209],"RESULTS:":[210],"Statistically":[211],"data":[212],"proved":[213],"Rivastigmine":[216],"showed":[218,273],"constant":[219],"values":[220],"MMSE,":[222],"compared":[223],"who":[230,272],"experienced":[231],"their":[234],"performances.":[236],"same":[238],"result":[239],"found":[241],"CDR,":[243],"ADL,":[244],"GDS":[245,262],"NPI":[247],"scales.":[248],"It":[249],"remarkable":[251],"underline":[253],"Rivastigmine-treated":[255],"had":[257],"mean":[259],"improvement":[260],"scales,":[263],"comparison":[265],"worsening":[275],"mood.":[277],"CONCLUSION:":[278],"Rivastigmine-therapy":[279],"improves":[280],"performance":[282],"elderly":[284],"SIVD.":[286]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}